Biologia e Farmacologia dell’invecchiamento, patologie infiammatorie, cancro e neurodegenerazione

Referenti: Marco Racchi, Cristina Lanni, Cristina Travelli, Erica Buoso

Settori ERC: LS – Life Sciences ERC subfields: LS7_4 Pharmacology and pharmacogenomics (including drug discovery and design, drug delivery and therapy, toxicology); LS4_4 Fundamental mechanisms underlying ageing; LS4_6 Fundamental mechanisms underlying cancer; LS5_1 Neural cell function, communication and signalling, neurotransmission in neuronal and/or glial cells; LS5_7 Neurological disorders (e.g. neurodegenerative diseases, seizures); LS6_4 Immunological mechanisms in disease (e.g. autoimmunity, allergy, transplantation immunology, tumour immunology)

Biologia e Farmacologia delle malattie oculari legate all’invecchiamento

Referente: Marialaura Amadio

Settori ERC: LS1 Molecules of Life: Biological Mechanisms, Structures and Functions, LS3 Cellular, Developmental and Regenerative Biology, LS4 Physiology in Health, Disease and Ageing, LS5 Neuroscience and Disorders of the Nervous System, LS7 Prevention, Diagnosis and Treatment of Human Diseases

Farmacologia cellulare e molecolare

Referenti: Sergio Schinelli, Mayra Paolillo, Cinzia Boselli

Settori ERC: LS1_9 Molecular mechanisms of signalling processes; LS3_5 Cell signalling and signal transduction, exosome biology; LS3_9 Cell differentiation, formation of tissues and organs; LS3_13 Stem cells; LS4_12 Cancer

Neurofarmacologia cellulare e molecolare

Referenti: Alessia Pascale, Annalisa Barbieri

Settori ERC: LS1_10 Molecular mechanisms of signalling pathways;  LS3_5 Cell signalling and signal transduction; LS5_1 Neural cell function, communication and signalling, neurotransmission in neuronal and/or glial cells; LS5_7 Neurological disorders (e.g. neurodegenerative diseases, seizures); LS7_4 Pharmacology and pharmacogenomics (including drug discovery and design, drug delivery and therapy, toxicology)